Life expectancy has risen substantially over the last century, but the years lived in good health have not risen by the same amount. The gap between the two is the central problem in ageing research.
The two measures track different things
Lifespan counts years lived. Healthspan attempts to count years lived without significant disease or functional limitation.
Healthspan is harder to measure, because it requires a decision about where health ends. Different definitions use self-reported limitation, diagnosed conditions or the ability to carry out daily tasks.
Whichever definition is used, the pattern is consistent. Healthspan is shorter than lifespan, and the difference has generally widened rather than narrowed.
Most gains came from preventing early death
The large improvements in life expectancy came from sanitation, vaccination, antibiotics and safer childbirth, which mostly removed deaths in infancy and early adulthood.
Those interventions added years by allowing people to reach old age. They did not slow the process of ageing once old age arrived.
The result is a population that reaches later life in far greater numbers, and therefore accumulates the conditions that appear in later life.
Treating one disease reveals the next
Medicine has become effective at converting fatal conditions into survivable ones. Heart attacks, strokes and many cancers are now often survived rather than avoided.
Survival transfers a person into a period of living with the consequences, and into the age range where a second condition becomes likely.
This is why disease-by-disease progress extends lifespan more reliably than it extends healthspan. Each success moves the endpoint without changing the trajectory.
Ageing itself is the common driver
The major chronic conditions share risk factors that are not independent of each other. The dominant one is chronological age.
Research into ageing biology is built on that observation. If the processes underlying decline could be slowed, several conditions would be delayed together rather than sequentially.
This is the reasoning behind treating ageing as a target in itself, though it remains a research direction rather than an established clinical practice.
Why the distinction changes what counts as success
An intervention that extends life without extending function adds years of dependency. An intervention that compresses decline into a shorter final period may not change life expectancy at all.
Trials increasingly report functional outcomes alongside mortality for that reason, measuring walking speed, grip strength and independence rather than survival alone.
Reading longevity claims carefully means asking which of the two a result actually moved, because headlines rarely distinguish them.